International Journal of Radiation Oncology * Biology * Physics
Volume 78, Issue 3 , Pages 651-658 , 1 November 2010

Treatment-Related Pneumonitis and Acute Esophagitis in Non–Small-Cell Lung Cancer Patients Treated With Chemotherapy and Helical Tomotherapy

  • Chang Hoon Song, M.D.

      Affiliations

    • Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Republic of Korea
    • ,
  • Hongryull Pyo, M.D.

      Affiliations

    • Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea
    • Corresponding Author InformationReprint requests to: Hongryull Pyo, M.D., Proton Therapy Center, Research Institute and Hospital, National Cancer Center, 809 Madu 1-dong, Ilsandong-gu, Goyang, Gyeonggi 410–769, Republic of Korea. Tel: +82-31-920-1723; Fax: +82-31-920-0149
    • ,
  • Sung Ho Moon, M.D.

      Affiliations

    • Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea
    • ,
  • Tae Hyun Kim, M.D.

      Affiliations

    • Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea
    • ,
  • Dae Woong Kim, B.S.

      Affiliations

    • Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea
    • ,
  • Kwan Ho Cho, M.D.

      Affiliations

    • Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea

Received 9 June 2009 ,Revised 26 August 2009 ,Accepted 27 August 2009.

References 

  1. Dillman RO, Seagren SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med. 1990;323:940–945
  2. Schaake-Koning C, van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med. 1992;326:524–530
  3. Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol. 1999;17:2692–2699
  4. Rosenzweig KE, Fox JL, Yorke E, et al. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Cancer. 2005;103:2118–2127
  5. Mehta M, Scrimger R, Mackie R, et al. A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2001;49:23–33
  6. Liu HH, Wang X, Dong L, et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;58:1268–1279
  7. Murshed H, Liu HH, Liao Z, et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;58:1258–1267
  8. Yom SS, Liao Z, Liu HH, et al. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68:94–102
  9. Sura S, Gupta V, Yorke E, et al. Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: The Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Radiother Oncol. 2008;87:17–23
  10. Mackie TR, Holmes T, Swerdloff S, et al. Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. Med Phys. 1993;20:1709–1719
  11. Woodford C, Yartsev S, Dar AR, et al. Adaptive radiotherapy planning on decreasing gross tumor volumes as seen on megavoltage computed tomography images. Int J Radiat Oncol Biol Phys. 2007;69:1316–1322
  12. Kupelian PA, Ramsey C, Meeks SL, et al. Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: Observations on tumor regression during treatment. Int J Radiat Oncol Biol Phys. 2005;63:1024–1028
  13. Ramsey CR, Langen KM, Kupelian PA, et al. A technique for adaptive image-guided helical tomotherapy for lung cancer. Int J Radiat Oncol Biol Phys. 2006;64:1237–1244
  14. Scrimger RA, Tome WA, Olivera GH, et al. Reduction in radiation dose to lung and other normal tissues using helical tomotherapy to treat lung cancer, in comparison to conventional field arrangements. Am J Clin Oncol. 2003;26:70–78
  15. Cattaneo GM, Dell'oca I, Broggi S, et al. Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC. Radiother Oncol. 2008;88:310–318
  16. Kron T, Grigorov G, Yu E, et al. Planning evaluation of radiotherapy for complex lung cancer cases using helical tomotherapy. Phys Med Biol. 2004;49:3675–3690
  17. Adkison JB, Khuntia D, Bentzen SM, et al. Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: Preliminary results of a risk-stratified phase I dose escalation study. Technol Cancer Res Treat. 2008;7:441–448
  18. Balog J, Olivera G, Kapatoes J. Clinical helical tomotherapy commissioning dosimetry. Med Phys. 2003;30:3097–3106
  19. Zatloukal P, Petruzelka L, Zemanova M, et al. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: A randomized study. Lung Cancer. 2004;46:87–98
  20. Lee SW, Choi EK, Lee JS, et al. Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2003;56:996–1004
  21. Cho KH, Ahn SJ, Pyo HR, et al. A Phase II Study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: Results of Korean Radiation Oncology Group 0301 Study. Int J Radiat Oncol Biol Phys. 2009;74:1397–1404
  22. Yamada M, Kudoh S, Hirata K, et al. Risk factors of pneumonitis following chemoradiotherapy for lung cancer. Eur J Cancer. 1998;34:71–75
  23. Byhardt RW, Scott C, Sause WT, et al. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. Int J Radiat Oncol Biol Phys. 1998;42:469–478
  24. Seppenwoolde Y, Lebesque JV, de Jaeger K, et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys. 2003;55:724–735
  25. Yorke ED, Jackson A, Rosenzweig KE, et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys. 2005;63:672–682
  26. Gopal R, Tucker SL, Komaki R, et al. The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys. 2003;56:106–113
  27. Wang S, Liao Z, Wei X, et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2006;66:1399–1407
  28. Schallenkamp JM, Miller RC, Brinkmann DH, et al. Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates. Int J Radiat Oncol Biol Phys. 2007;67:410–416
  29. Allen AM, Czerminska M, Janne PA, et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys. 2006;65:640–645
  30. Rice DC, Smythe WR, Liao Z, et al. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2007;69:350–357
  31. Liu HH, Jauregui M, Zhang X, et al. Beam angle optimization and reduction for intensity-modulated radiation therapy of non-small-cell lung cancers. Int J Radiat Oncol Biol Phys. 2006;65:561–572
  32. TomoDirect. Available online at: http://www.tomotherapy.com/images/backgrounders/TomoDirect.pdf. Accessed October 5, 2009.

 Conflict of interest: none.

PII: S0360-3016(09)03047-8

doi: 10.1016/j.ijrobp.2009.08.068

International Journal of Radiation Oncology * Biology * Physics
Volume 78, Issue 3 , Pages 651-658 , 1 November 2010

Article Tools

* Image Usage & Resolution